Professor Elio Riboli is Chair in Cancer Epidemiology and Prevention and was formerly the Director of the School of Public Health at Imperial College London, rated one of the top two epidemiology and public health submissions to the UK’s Research Assessment Exercise (RAE) in 2009. He holds an M.D. degree (1977, State University of Milan), a Master of Public Health (1980, Milan) and a Master of Science in Epidemiology (1982, Harvard University). Professor Riboli is a Registered Physician (General Medical Council, UK, 2005) and an Honorary Fellow of the Royal College of Physicians (2008).
From 1983 to 2005 Professor Riboli was based at Lyon’s the International Agency for Research on Cancer (IARC), where he developed new research projects in the areas of nutrition, nutritional status and cancer. In 1989 he initiated the European Prospective Investigation into Cancer and Nutrition (EPIC), which sampled data from 500,000 subjects across 26 centres in ten countries. He was Head of the Nutrition and Hormones Group of IARC from 2004 to 2005.
Professor Riboli has co-authored over 310 peer-reviewed publications and over 100 book chapters and books and serves on editorial boards of major journals on nutrition, cancer and epidemiology.
In 2005 he joined Imperial College London as Professor of Cancer Epidemiology; in 2006 he was appointed Divisional Head of Epidemiology, Public Health and Primary Care, which later become the School of Public Health. Professor Riboli stepped down as Head of the School at the end of 2017.
et al., Inflammatory potential of the diet & risk of gastric cancer in the European Investigation into Cancer & Nutrition, American Journal of Clinical Nutrition, ISSN:1938-3207
Riboli E, Interaction of dietary and genetic factors influencing body iron status and risk of type 2 diabetes within the EPIC-InterAct Study.Gene-Haem iron interactions and type 2 diabetes, Diabetes Care, ISSN:0149-5992
et al., KIM-1 as a blood-based marker for early detection of kidney cancer: a prospective nested case-control study., Clinical Cancer Research, ISSN:1078-0432
et al., 2018, Tumor-associated autoantibodies as early detection markers for ovarian cancer? A prospective evaluation, International Journal of Cancer, Vol:143, ISSN:0020-7136, Pages:515-526
et al., 2018, Prospective evaluation of antibody response to Streptococcus gallolyticus and risk of colorectal cancer, International Journal of Cancer, Vol:143, ISSN:0020-7136, Pages:245-252